Advertisement

Topics

PEACOCK MYERS,P.C. Company Profile

14:12 EDT 20th September 2018 | BioPortfolio

Nil

Location

P.O. Box 26927
Albuquerque
New Mexico
87125
United States of America

Contact

Phone: (505) 998-1500
Fax: (505) 243-2542
Email: info@PeacockLaw.com


News Articles [380 Associated News Articles listed on BioPortfolio]

Bristol-Myers Squibb And Flatiron Health Expand Collaboration

NewsBristol-Myers Squibb will use Flatiron’s real-world data to accelerate its research and development efforts, as well as improve its ability to generate additional evidence on the use of its canc...

Bumblebees Confused by Iridescent Colors

Iridescence is common in nature, from the dazzling blues of peacock's feathers, to the gem-like appearance of insects

Bristol-Myers Squibb And Gritstone Oncology Enter Clinical Research Collaboration

NewsBristol-Myers Squibb and Gritstone Oncology have entered into a clinical trial collaboration to evaluate the safety and tolerability of Gritstone’s personalized neoantigen immunotherapy in combi...

Bristol-Myers Squibb and Flatiron to collaborate on RWE

Bristol-Myers Squibb and Flatiron have expanded their relationship by announcing a three-year collaboration agreement focused on the use of real...Read More... The post Bristol-Myers Squibb and Flatir...

Bristol-Myers Squibb Receives Positive European Agency Opinion

NewsBristol-Myers Squibb receives positive CHMP opinion recommending approval of Opdivo four-week dosing schedule for advanced melanoma and previously treated renal cell carcinoma.

Bristol-Myers reports positive 1st-qtr growth against currency headwinds

New York’s Bristol-Myers Squibb has reported a mixed bag of financial results from the first quarter…

More fallout from epacadostat failure as Bristol-Myers drops IDO blocker

New York’s Bristol-Myers Squibb is reportedly the latest drugmaker to step away from development of…

Bristol-Myers Squibb (BMY) Expected to Announce Quarterly Sales of $5.38 Billion

Brokerages forecast that Bristol-Myers Squibb will post $5.38 billion in sales for the current fiscal quarter, according to Zacks Investment Research . Four analysts have made estimates for Bristol-My...

Clinical Trials [52 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

To compare the single-dose bioavailability of Par and Bristol-Myers Squibb Buspirone HCl Tablets

Companies [90 Associated Companies listed on BioPortfolio]

PEACOCK MYERS,P.C.

Nil

Bristol-Myers Squibb and Pfizer

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Pfizer Inc. & Bristol-Myers Squibb

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb Company and Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize Eliquis, an oral anticoagulant discovered by Bristol-Myers Squibb. Thi...

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...

More Information about "PEACOCK MYERS,P.C." on BioPortfolio

We have published hundreds of PEACOCK MYERS,P.C. news stories on BioPortfolio along with dozens of PEACOCK MYERS,P.C. Clinical Trials and PubMed Articles about PEACOCK MYERS,P.C. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PEACOCK MYERS,P.C. Companies in our database. You can also find out about relevant PEACOCK MYERS,P.C. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record